321 related articles for article (PubMed ID: 31551581)
21. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
Qin J; Zhou C; Zhu M; Shi S; Zhang L; Zhao Y; Li C; Wang Y; Wang Y
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
[TBL] [Abstract][Full Text] [Related]
22. In-Vitro Use of 5-ALA for Photodynamic Therapy in Pediatric Brain Tumors.
Schwake M; Nemes A; Dondrop J; Schroeteler J; Schipmann S; Senner V; Stummer W; Ewelt C
Neurosurgery; 2018 Dec; 83(6):1328-1337. PubMed ID: 29538709
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Photodynamic Therapy Using 5-Aminolevulinic Acid in Bone and Soft Tissue Sarcoma Cells.
Adachi R; Nakamura T; Nakata K; Uchiyama T; Hagi T; Asanuma K; Sudo A
Anticancer Res; 2024 Mar; 44(3):963-969. PubMed ID: 38423650
[TBL] [Abstract][Full Text] [Related]
24. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
[TBL] [Abstract][Full Text] [Related]
25. Quinolone compounds enhance delta-aminolevulinic acid-induced accumulation of protoporphyrin IX and photosensitivity of tumour cells.
Ohgari Y; Miyata Y; Chau TT; Kitajima S; Adachi Y; Taketani S
J Biochem; 2011 Feb; 149(2):153-60. PubMed ID: 20961864
[TBL] [Abstract][Full Text] [Related]
26. eEF1A1 binds and enriches protoporphyrin IX in cancer cells in 5-aminolevulinic acid based photodynamic therapy.
Fan Z; Cui X; Wei D; Liu W; Li B; He H; Ye H; Zhu N; Wei X
Sci Rep; 2016 May; 6():25353. PubMed ID: 27150264
[TBL] [Abstract][Full Text] [Related]
27. Ablation efficacy of 5-aminolevulinic acid-mediated photodynamic therapy on human glioma stem cells.
Omura N; Nonoguchi N; Fujishiro T; Park Y; Ikeda N; Kajimoto Y; Hosomi R; Yagi R; Hiramatsu R; Furuse M; Kawabata S; Fukunaga K; Kuroiwa T; Nakano I; Wanibuchi M
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103119. PubMed ID: 36336324
[TBL] [Abstract][Full Text] [Related]
28. Reactive Oxygen Species Produced by 5-Aminolevulinic Acid Photodynamic Therapy in the Treatment of Cancer.
Pignatelli P; Umme S; D'Antonio DL; Piattelli A; Curia MC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240309
[TBL] [Abstract][Full Text] [Related]
29. Nanoparticles drug delivery for 5-aminolevulinic acid (5-ALA) in photodynamic therapy (PDT) for multiple cancer treatment: a critical review on biosynthesis, detection, and therapeutic applications.
Bhattacharya S; Prajapati BG; Singh S; Anjum MM
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17607-17634. PubMed ID: 37776358
[TBL] [Abstract][Full Text] [Related]
30. Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells.
Kim CH; Chung CW; Choi KH; Yoo JJ; Kim DH; Jeong YI; Kang DH
Int J Nanomedicine; 2011; 6():1357-63. PubMed ID: 21760730
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia.
Yanase S; Nomura J; Matsumura Y; Nagai K; Kinoshita M; Nakanishi H; Ohnishi Y; Tokuda T; Tagawa T
Int J Oncol; 2005 Jul; 27(1):193-201. PubMed ID: 15942660
[TBL] [Abstract][Full Text] [Related]
32. Mitomycin C-induced cell cycle arrest enhances 5-aminolevulinic acid-based photodynamic therapy for bladder cancer.
Nakayama T; Nozawa N; Kawada C; Yamamoto S; Ishii T; Ishizuka M; Namikawa T; Ogura SI; Hanazaki K; Inoue K; Karashima T
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101893. PubMed ID: 32592910
[TBL] [Abstract][Full Text] [Related]
33. Development of a novel Schiff base derivative for enhancing the anticancer potential of 5-aminolevulinic acid-based photodynamic therapy.
Shinohara Y; Endo Y; Abe C; Shiba I; Ishizuka M; Tanaka T; Yonemura Y; Ogura SI; Tominaga M; Yamada H; Uto Y
Photodiagnosis Photodyn Ther; 2017 Dec; 20():182-188. PubMed ID: 29056554
[TBL] [Abstract][Full Text] [Related]
34. Predictors of therapeutic efficacy of 5-aminolevulinic acid-based photodynamic therapy in human prostate cancer.
Yamamoto S; Fukuhara H; Seki H; Kawada C; Nakayama T; Karashima T; Ogura SI; Inoue K
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102452. PubMed ID: 34303032
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
36. 5-aminolevulinic acid and sodium ferrous citrate decreased cell viability of gastric cancer cells by enhanced ROS generation through improving COX activity.
Suprihadi A; Pustimbara A; Ogura SI
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103055. PubMed ID: 35934181
[TBL] [Abstract][Full Text] [Related]
37. Sulforaphene Enhances The Efficacy of Photodynamic Therapy In Anaplastic Thyroid Cancer Through Ras/RAF/MEK/ERK Pathway Suppression.
Chatterjee S; Rhee Y; Chung PS; Ge RF; Ahn JC
J Photochem Photobiol B; 2018 Feb; 179():46-53. PubMed ID: 29331658
[TBL] [Abstract][Full Text] [Related]
38. Modulating ALA-PDT efficacy of mutlidrug resistant MCF-7 breast cancer cells using ALA prodrug.
Feuerstein T; Berkovitch-Luria G; Nudelman A; Rephaeli A; Malik Z
Photochem Photobiol Sci; 2011 Dec; 10(12):1926-33. PubMed ID: 22020364
[TBL] [Abstract][Full Text] [Related]
39. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
[TBL] [Abstract][Full Text] [Related]
40. 5-Aminolevulinic acid-mediated photodynamic therapy using light-emitting diodes of different wavelengths in a mouse model of peritoneally disseminated gastric cancer.
Hino H; Murayama Y; Nakanishi M; Inoue K; Nakajima M; Otsuji E
J Surg Res; 2013 Nov; 185(1):119-26. PubMed ID: 23746762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]